American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 33-42 , July 2009

Comparison of Drug Dosing Recommendations Based on Measured GFR and Kidney Function Estimating Equations

  • Lesley A. Stevens, MD, MS

      Affiliations

    • Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Lesley A. Stevens, MD, MS, Division of Nephrology, Tufts Medical Center, 800 Washington St, Box 391, Boston, MA 02111
  • ,
  • Thomas D. Nolin, PharmD, PhD

      Affiliations

    • University of Pittsburgh School of Pharmacy, Pittsburgh, PA
  • ,
  • Michelle M. Richardson, PharmD

      Affiliations

    • Tufts Medical Center, Boston, MA
  • ,
  • Harold I. Feldman, MD, MSCE

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA
  • ,
  • Julia B. Lewis, MD

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA
    • Vanderbilt University, Nashville, TN
  • ,
  • Roger Rodby, MD

      Affiliations

    • Rush University Medical Center, Chicago, IL
  • ,
  • Raymond Townsend, MD

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA
  • ,
  • Aghogho Okparavero, MBBS, MPH

      Affiliations

    • Tufts Medical Center, Boston, MA
  • ,
  • Yaping (Lucy) Zhang, MS

      Affiliations

    • Tufts Medical Center, Boston, MA
  • ,
  • Christopher H. Schmid, PhD

      Affiliations

    • Tufts Medical Center, Boston, MA
  • ,
  • Andrew S. Levey, MD

      Affiliations

    • Tufts Medical Center, Boston, MA
  • ,
  • Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)

Received 29 December 2008 ,Accepted 18 March 2009.

References 

  1. Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients With Impaired Renal Function—Study Design, Data Analysis, and Impact on Dosing and Labeling. Rockville, MD: US Department of Health and Human Services; 1998;May
  2. Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis. 2007;50:21–35
  3. Coresh J, Stevens LA. Kidney function estimating equations: Where do we stand?. Curr Opin Nephrol Hypertens. 2006;15:276–284
  4. Lewis JB, Agodoa L, Cheek D, et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis. 2001;38:744–753
  5. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773
  6. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929–937
  7. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16:459–466
  8. Cirillo M, Anastasio P, De Santo N. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791–1798
  9. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis. 2005;46:233–241
  10. Levey AS, Coresh J, Greene T, et al. Expressing the MDRD Study equation for estimating GFR with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  11. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  12. National Kidney Disease Education Program. Laboratory Professionals. http://nkdep.nih.gov/labprofessionals/index.htmAccessed December 19, 2008
  13. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52:5–18
  14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  15. Australian and New Zealand Society of Nephrology (ANZSN). Kidney Check Australia Taskforce. www.nephrology.edu.auAccessed December 19, 2008
  16. Miller WG. Reporting estimated GFR: A laboratory perspective. Am J Kidney Dis. 2008;52:645–648
  17. La Caisse nationale d'assurance maladie des professions indépendantes: Avenant à la convention nationale des directeurs de laboratoire privé d'analyses médicales. http://www.admi.net/jo/20030227/SANS0320604X.htmlAccessed December 22, 2008
  18. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: A position statement. Med J Aust. 2005;183:138–141
  19. Siegel NJ. Renal Express. http://www.asn-online.org/newsletter/renal_express/2003/03-10_Rxpress.aspxAccessed October 3, 2003
  20. Rosborough TK, Shepherd MF, Couch PL. Selecting an equation to estimate glomerular filtration rate for use in renal dosage adjustment of drugs in electronic patient record systems. Pharmacotherapy. 2005;25:823–830
  21. Wargo KA, Eiland EH, Hamm W, English TM, Phillippe HM. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for antimicrobial dosage adjustments. Ann Pharmacother. 2006;40:1248–1253
  22. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus Modification of Diet in Renal Disease: Importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2008;51:991–996
  23. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group—A cautionary tale. Nephrol Dial Transplant. 2007;22:2894–2899
  24. Golik M, Lawrence K. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and Modification of Diet in Renal Disease. Pharmacotherapy. 2008;28:1125–1132
  25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  26. Spinler SA, Awarskas JJ, Boyce EG, et al. Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Ann Pharmacother. 1998;32:1275–1283
  27. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098
  28. Thomson Healthcare Staff. Physicians' Desk Reference. (ed 62). Montvale, NJ: Physicians' Desk Reference Inc; 2008;
  29. AstraZeneca Pharmaceuticals. Product Information: Tenormin®, atenolol. Wilmington, DE: AstraZeneca Pharmaceuticals; 2005;
  30. SmithKline Beecham. Product Information: Ancef®, cefazolin. Philadelphia, PA: SmithKline Beecham; 2004;
  31. Aronoff GR, Berns JS, Brier ME, et al. Drug Prescribing in Renal Failure (Dosing Guidelines for Adults). (ed 4). Philadelphia, PA: American College of Physicians; 1999;
  32. Ortho-McNeil Pharmaceutical Inc. Product Information: Ultram®, tramadol hydrochloride. Raritan, NJ: Ortho-McNeil Pharmaceutical Inc; 2007;
  33. Pfizer Inc. Product Information: Neurontin®, gabapentin. New York, NY: Pfizer Inc; 2007;
  34. Berlex Laboratories. Product Information: Betapace®, sotalol HCl. Wayne, NJ: Berlex Laboratories; 2001;
  35. Searle Pharmaceuticals. Product Information: Norpace®, disopyramide. Chicago, IL: Searle Pharmaceuticals; 1995;
  36. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  37. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transpl. 2004;10:301–309
  38. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail. 2006;8:63–67
  39. Rigalleau V, Lasseur C, Perlemoine C, et al. Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism. 2006;55:108–112
  40. de Lemos ML, Hsieh T, Hamata L, et al. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol. 2006;103:1063–1069
  41. Launay-Vacher V, Izzedine H, Karie SHJ, Baumelou A, Deray G. Renal tubular drug transporters. Nephron Physiol. 2006;103:97–106
  42. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the Modification of Diet in Renal Disease Study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749–2757
  43. Poggio ED, Nef PC, Wang X, et al. Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis. 2005;46:242–252

 Originally published online as doi: 10.1053/j.ajkd.2009.03.008 on May 18, 2009.

 A list of the CKD-EPI investigators and collaborators appears at the end of this article.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Kamal Badr, MD, Lebanese American University) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(09)00601-5

doi: 10.1053/j.ajkd.2009.03.008

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 33-42 , July 2009